Irodalom:
1. Tulassay Zs, Rácz K.: Carcinoid Tumorok MBA supplementum 2006/1
2. Zalatnai A.: A carcinoidtól a neuroendokrin tumorokig. Orvosképzés. 2006;3:137:-24
3. Musunuru S, Carpenter JE, Sippel RS: A mouse model of carcinoid syndrome and heart disease. J Surg
Res 2005;126:102-105
4. Mizuno S,Kimitoshi K, Hashimoto A et al: Expression of Cyclo-oxygenase-2 in gastrointetinal carcinoid
tumors J Gastroenterol Hepatol 2006;21 (8):1313-1319
5. Helland SK et al: Carcinoid tumors in gastrointestinal trac t- a polpulation-based study from Western
Norway. Scand J Surg. 2006;95:158-61
6. Jennifer A. et al.: Large bowel carcinoid tumors Curr.Opin Gastroenterol 2007;23:74-78
7. I. Modlin, A.K.C Chan et al: Gastrointestinal Carcinoids: The Evolution of Diagnostic Strategies J Clin
Gastroenterol 2006;40:572-582
8. L. Michael et al: Dull Abdominal pain Caused by Non-functional Metastatic Neuroendocrin Tumor
IMAJ 2006;8:716-717
9. Modlin I., Murren J, Lyle K et al: 111Indium-labeled somatostatin analogues: a novel advance int he
management of unresectable NETs. Cancer 2006 In press
10. Varas Lorenzo M.J. et al: Preoperative detection of gastrointestinal neuroendocrine zumors using endoscopic
ultrasonography. Rev Esp Enferm Dig 2006 ;98 828-836
11. Akerström G: Midgut carcinoid tumors: surgical treatment and prognosis Best Practice and Research
2005 Vol19, No.5pp 717-728
12. Bailey A. et al: Am.J. Gastroenterol 2006;101:2237-2243
13. Modlin IM, Latich I, Kidd M,Zikosuka M, Eick G: Therapeutic options for gastrointetinal carcinoids.
Clin Gastroenterol Hepatol 2006;4:526-4
14. Oberg K. , Eriksson B: Nuclear medicine in detection, staging and treatment of gastrointestinal carcinod
tumors best Pract Res Clin Endocrin Metab 2005;19:265-276
15. Northop J.A. , Lee J. H: Large bowel carcinoid tumors Curr Opin Gastroenterol 2007;23:74-78
16. Akerström G., Hellman P., Hessman O: Midgut carcinoid tumors: surgical treatment and prognosis Best
Practice and Research 2005 Vol19, No.5pp 717-728
17. Akerström G. et al: Endocrine Surgery 3rd edition, Elsevier, 2006
18. Lal A., ChenH: Treatment of advanced carcinoid tumors Curr. Opin Oncol 2006;18:9-15
19. Touzios JG, Kieli JM Pitt S cet al: Neuroendocrin hepatic metastases: does aggressive management
impreve survival? Ann Surg 2005;241 776-783
20. Touzios JG, Kieli JM Pitt S cet al: Neuroendocrin hepatic metastases: does aggressive management
impreve survival? Ann Surg 2005;241 776-783
21. Elias D, Sideris L, Liberale G: Surgical treatment of peritoneal carcinomatosis from well-differentiated
digestive endocrine carcinomas. Surgery 2005 137;411-416.
22. Strosberg J.R., Choi J, Kvols A: Selective hepatic artery embolizatio for treatment of patients with
576 Gastro Update 2007
metastaticcarcinoid and pancreatic endocrine tumors. Cancer Control 2006;13 (1):72-76
23. Sakata H., Iwakiri R, Ootani A, et al: A pilot randomized control study to evaluate endoscopic resection
using a ligation devics for rectal carcinoid tumors World J Gastroenterol 2006; 12 (25):4026-8
24. Kulke M. et al: New oral regimen active against pancreatic neuroendocrine tumor J. Clin Oncol
2006;24:401-406
25. Bajetta E, Procopio G, Catena L et al: Lanreotide autogel every 6 weeks compared with Lanreotide
microparticles every 3 weeks in patients with well differentieted neuroendocrin tumors: a Phase III
study. Cancer 2006;107 (10):2474-81
26. Katai M, Sakurai A, Inaba H: Octreotide as a rapid and effective painkiller for metastatic carcinoid
tumor Endocr J 2005;52:277-280
27. Bondanelli M, Ambriosos MR, Zatelli MC: Regression of liver metastases of occult carcinoid tumor
with slww release lanreotide therapy. World J Gatroenterol 2005; 11: 2041-2044
28. Van Gompel JJ et al: ZM336372, a Raf-1 activator, suppress growth and neuroendocrine hormone levels
in carcinoid tumor cells. Molecular Cancer Therapeutics 2005;4:910-917
29. Kunnimalayiaan M, TraegerK, Chen H: Conservation of the Notch 1 signaling pathway of gastrointetinals
carcinoid cells. Am J PhysiolGastrointest Liver Physiol 2005; 289:G636-G642
30. Szilvás Á, Székely Gy.: Lantreotide autogel therapy in metastatic carcinoid tumour controlled by
ultrasonography and tumour markers. Z Gastroenterol 2006;43:411-458
